Department of Medical Physics, School of Medicine, University of Patras, 26504 Patras, Greece.
Department of Medical Physics, University Hospital of Patras, 26504 Patras, Greece.
Radiat Prot Dosimetry. 2021 Jul 14;194(2-3):121-134. doi: 10.1093/rpd/ncab082.
This study aims to evaluate patient radiation dose during fluoroscopically guided endovascular aneurysm repair (EVAR) procedures. Fluoroscopy time (FT) and kerma-area product (KAP) were recorded from 87 patients that underwent EVAR procedures with a mobile C-arm fluoroscopy system. Effective dose (ED) and organs' doses were calculated utilising appropriate conversion coefficients based on the recorded KAP values. Entrance surface dose (ESD) was calculated based on KAP values and technical parameters. The mean FT was 22.7 min (range 6.4-76.8 min), resulting in a mean KAP of 36.6 Gy cm2 (range 2.0-167.8 Gy cm2), a mean ED of 6.2 mSv (range 0.3-28.5 mSv) and a mean ESD of 458 mGy (range 26-2098 mGy). The corresponding median values were 17.4 min, 25.6 Gy cm2, 4.4 mSv and 320 mGy. The threshold of 2 Gy for skin erythema was exceeded in two procedures for a focus-to-skin distance (FSD) of 40 cm and six procedures when an FSD of 30 cm was considered. The highest doses absorbed by the adrenals, kidneys, spleen and pancreas and ranged between 3.7 and 313.3 mGy (average 66.8 mGy), 3.3 and 285.1 mGy (average 60.8 mGy), 1.3 and 111.1 mGy (average 23.7 mGy), 1.1 and 92.1 mGy (average 19.6 mGy), respectively. A wide range of patient doses was reported in the literature. The radiation dose received by the patients was comparative or lower than most of the previously reported values. However, higher doses can be revealed due to the X-ray system's non-optimum use and extended FTs, mainly affected by complex clinical conditions, patients' body habitus and vascular surgeon experience. The large variation of patient doses highlights the potential to optimise the EVAR procedure by considering the balance between the radiation dose and the required image quality. Additional studies need to be conducted in increasing the vascular surgeons' awareness regarding patient dose and radiation protection issues during EVAR procedures.
本研究旨在评估在透视引导下进行血管内动脉瘤修复(EVAR)手术过程中的患者辐射剂量。对 87 例行 EVAR 手术的患者使用移动 C 臂透视系统记录透视时间(FT)和比释动能面积乘积(KAP)。利用基于记录 KAP 值的适当转换系数计算有效剂量(ED)和器官剂量。根据 KAP 值和技术参数计算入射体表剂量(ESD)。平均 FT 为 22.7 分钟(范围 6.4-76.8 分钟),导致平均 KAP 为 36.6 Gy·cm2(范围 2.0-167.8 Gy·cm2),平均 ED 为 6.2 mSv(范围 0.3-28.5 mSv),平均 ESD 为 458 mGy(范围 26-2098 mGy)。中位数分别为 17.4 分钟、25.6 Gy·cm2、4.4 mSv 和 320 mGy。对于 FSD 为 40 cm 的两次手术和 FSD 为 30 cm 的六次手术,皮肤红斑的 2 Gy 阈值超过了两次手术和六次手术。肾上腺、肾脏、脾脏和胰腺吸收的最高剂量在 3.7 和 313.3 mGy(平均 66.8 mGy)、3.3 和 285.1 mGy(平均 60.8 mGy)、1.3 和 111.1 mGy(平均 23.7 mGy)、1.1 和 92.1 mGy(平均 19.6 mGy)之间。文献中报道了患者剂量的广泛范围。患者接受的辐射剂量与大多数先前报道的值相当或更低。然而,由于 X 射线系统的使用不理想和 FT 延长,可能会出现更高的剂量,这主要受复杂的临床情况、患者的体型和血管外科医生的经验影响。患者剂量的巨大差异突出了通过考虑辐射剂量和所需图像质量之间的平衡来优化 EVAR 手术的潜力。需要进一步开展研究,以提高血管外科医生对 EVAR 手术过程中患者剂量和辐射防护问题的认识。